Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Merck (MRK) hired Dr. Nicholas Haining as vice president, oncology for discover, pre-clinical and early development. He starts work in January 2019. He is currently an associate professor of pediatrics at Harvard Medical School and an associate member of the Broad Institute of Harvard and MIT.
About the Author Reprints
